An antibody cocktail is now beginning late-stage clinical trials to evaluate the drug’s ability to prevent and treat coronavirus infection.
Covid-19 antibody drug that might treat and prevent infection enters phase 3 trial, Regeneron says
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over